Click here for
subscription
information.
Corcept Therapeutics (CORT)

Coverage Initiated: September 2004

Corcept Therapeutics (CORT)
is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Its lead product candidate, Corlux, is aimed at treating psychotic depression and Cushing’s syndrome.


Archive of our research on CORT

A complete listing of our research on Corcept Therapeutics is available by clicking here.




© 2006-2010 Biotech Stock Research, LLC. Use of this site is governed by the Terms and Conditions.